跳至主要内容
临床试验/ITMCTR2200005691
ITMCTR2200005691尚未招募4 期

A prospective, multicenter, randomized, open parallel controlled clinical trial of Tongren Wuji Baifeng Pill in the treatment of hyperuricemia in patients with chronic kidney disease

Guang'anmen Hospital of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
All

入选标准

  • (1) Age 18-70 years old, regardless of gender
  • (2) Patients meeting the diagnostic criteria for CKD and staged as CKD stage 2-4 (15 ml/min.1.73m2=GFR<90 ml/min.1.73m2)
  • (3) Meeting the diagnostic criteria of hyperuricemia
  • (4) Patients with evidence of spleen and kidney deficiency and blood deficiency with stasis
  • (5) Signed informed consent form

排除标准

  • (1) Taking one or more of the Western medicine uric acid-lowering drugs, such as allopurinol, benzbromarone, probenecid, febuxostat, etc. within the last 1 month
  • (2) Uncontrollable hypertension/hypotension: systolic blood pressure = 200 mmHg or diastolic blood pressure = 110 mmHg; or systolic blood pressure = 90 mmHg or diastolic blood pressure = 60 mmHg
  • (3) Change in blood creatinine level of more than 50% in the last 3 months
  • (4) Combination of various acute infections, or with severe infections, severe anaemia, etc.
  • (5) History or complications of malignancy
  • (6) Organic heart disease, such as congenital heart disease, rheumatic heart disease, etc.
  • (7) Severe liver function abnormalities (ALT or AST greater than 3 times the upper limit of normal)
  • (8) Pregnant or lactating women
  • (9) Participating in any other clinical trial
  • (10) Any other reason why the investigator considers it inappropriate to participate in this study

研究者

相似试验

进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741
EUCTR2004-002380-24-HUycomed Danmark ApS, International Medical Affairs300
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741
EUCTR2004-002380-24-BEycomed Danmark ApS, International Medical Affairs300
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741
EUCTR2004-002380-24-DEycomed Danmark ApS, International Medical Affairs300
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomy
EUCTR2004-002380-24-SEycomed Danmark ApS, International Medical Affairs300
进行中(未招募)
不适用
An open randomised, prospective, multi-centre, parallel-group trial to compare efficacy and safety of TachoSil versus standard surgical treatment in patients undergoing pulmonary lobectomy for lung malingnancy and requiring treatment for air leakage. - TachoSil versus standard surgical treatment for air leakage in pulmonary lobectomyManagement of pulmonary air leakage following lobectomy in subjects with lung malignancies including metastases.MedDRA version: 8.1Level: PTClassification code 10024741
EUCTR2004-002380-24-ATycomed Danmark ApS, International Medical Affairs300
Clinical study of Tongren Wuji Baifeng Pill in the... | 临床试验